{"id":48165,"date":"2022-09-09T15:01:48","date_gmt":"2022-09-09T13:01:48","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/zoetis-to-participate-in-the-morgan-stanley-20th-annual-global-healthcare-conference\/"},"modified":"2022-09-09T15:01:48","modified_gmt":"2022-09-09T13:01:48","slug":"zoetis-to-participate-in-the-morgan-stanley-20th-annual-global-healthcare-conference","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/zoetis-to-participate-in-the-morgan-stanley-20th-annual-global-healthcare-conference\/","title":{"rendered":"Zoetis to Participate in the Morgan Stanley 20th Annual Global Healthcare Conference"},"content":{"rendered":"<div>\n<p>PARSIPPANY, N.J.&#8211;(BUSINESS WIRE)&#8211;<a href=\"https:\/\/twitter.com\/search?q=%24ZTS&amp;src=ctag\" target=\"_blank\" rel=\"noopener\">$ZTS<\/a> <a href=\"https:\/\/twitter.com\/hashtag\/Fortune500?src=hash\" target=\"_blank\" rel=\"noopener\">#Fortune500<\/a>&#8212;<a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.zoetis.com&amp;esheet=52876637&amp;newsitemid=20220908005770&amp;lan=en-US&amp;anchor=Zoetis+Inc.&amp;index=1&amp;md5=2f1bc42788d2c07e62c8a8218c039a9b\" rel=\"nofollow noopener\" shape=\"rect\">Zoetis Inc.<\/a> (NYSE:ZTS) will participate in the Morgan Stanley 20th Annual Global Healthcare Conference on Tuesday, September 13, 2022. Wetteny Joseph, Executive Vice President and Chief Financial Officer, will represent the company and respond to questions from analysts. He is scheduled to present at 2:05 p.m. ET.\n<\/p>\n<p><a href=\"https:\/\/mms.businesswire.com\/media\/20220908005770\/en\/356607\/5\/Zoetis_c.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20220908005770\/en\/356607\/21\/Zoetis_c.jpg\"><\/a><\/p>\n<p>\nInvestors and other interested parties will be able to access a live audio webcast of the presentation by visiting <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Finvestor.zoetis.com%2Fevents-presentations&amp;esheet=52876637&amp;newsitemid=20220908005770&amp;lan=en-US&amp;anchor=http%3A%2F%2Finvestor.zoetis.com%2Fevents-presentations&amp;index=2&amp;md5=deb62b533d10912ae684b6ccf5c5ca7f\" rel=\"nofollow noopener\" shape=\"rect\">http:\/\/investor.zoetis.com\/events-presentations<\/a>. A replay of the presentation will also be available on the Zoetis website at the conclusion of the event.\n<\/p>\n<p>\n<b>About Zoetis<\/b>\n<\/p>\n<p>\nAs the world\u2019s leading animal health company, Zoetis is driven by a singular purpose: to nurture our world and humankind by advancing care for animals. After 70 years innovating ways to predict, prevent, detect, and treat animal illness, Zoetis continues to stand by those raising and caring for animals worldwide \u2013 from livestock farmers to veterinarians and pet owners. The company\u2019s leading portfolio and pipeline of medicines, vaccines, diagnostics and technologies make a difference in over 100 countries. A Fortune 500 company, Zoetis generated revenue of $7.8 billion in 2021 with approximately 12,100 employees. For more information, visit <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.zoetis.com&amp;esheet=52876637&amp;newsitemid=20220908005770&amp;lan=en-US&amp;anchor=www.zoetis.com&amp;index=3&amp;md5=75b26a3229c30b34c9888b3f20e7153a\" rel=\"nofollow noopener\" shape=\"rect\">www.zoetis.com<\/a>.\n<\/p>\n<p>\n<i>ZTS-COR<br \/>\n<br \/><\/i><i>ZTS-IR<\/i>\n<\/p>\n<p> <b>Contacts<\/b> <\/p>\n<p>\n<span class=\"bwuline\">Media Contacts<\/span>:<br \/>\n<br \/>Bill Price<br \/>\n<br \/>1-973-443-2742 (o)<br \/>\n<br \/><a target=\"_blank\" href=\"&#109;&#x61;&#x69;l&#116;&#x6f;&#x3a;w&#105;&#x6c;l&#105;&#x61;&#x6d;&#46;&#112;&#x72;i&#99;&#x65;&#x40;z&#111;&#x65;&#x74;&#105;&#x73;&#x2e;c&#111;&#x6d;\" rel=\"nofollow noopener\" shape=\"rect\">&#x77;i&#x6c;&#108;&#x69;&#x61;m&#x2e;&#112;&#x72;&#x69;c&#x65;&#64;&#x7a;&#x6f;e&#x74;&#105;&#x73;&#x2e;c&#x6f;&#109;<\/a><\/p>\n<p>Kristen Seely<br \/>\n<br \/>1-973-443-2777 (o)<br \/>\n<br \/><a target=\"_blank\" href=\"&#x6d;a&#x69;&#108;t&#x6f;&#58;&#x6b;&#x72;i&#x73;&#116;e&#x6e;&#46;&#x73;&#101;e&#x6c;&#121;&#64;&#x7a;&#111;&#x65;&#116;i&#x73;&#46;&#x63;&#x6f;m\" rel=\"nofollow noopener\" shape=\"rect\">&#x6b;&#114;i&#x73;&#116;&#101;&#x6e;&#x2e;&#115;e&#x65;&#108;y&#x40;&#x7a;&#111;e&#x74;&#105;s&#x2e;&#x63;&#111;m<\/a><\/p>\n<p><span class=\"bwuline\">Investor Contact<\/span>:<br \/>\n<br \/>Steve Frank<br \/>\n<br \/>1-973-822-7141 (o)<br \/>\n<br \/><a target=\"_blank\" href=\"&#x6d;&#97;&#x69;&#x6c;&#116;&#x6f;&#58;s&#x74;&#101;v&#x65;&#46;f&#x72;&#97;n&#x6b;&#64;&#x7a;&#x6f;&#101;&#x74;&#x69;&#115;&#x2e;&#99;o&#x6d;\" rel=\"nofollow noopener\" shape=\"rect\">ste&#118;&#101;&#46;&#x66;&#x72;&#x61;&#x6e;&#x6b;&#x40;zoe&#116;&#105;&#115;&#46;&#x63;&#x6f;&#x6d;<\/a><\/p>\n<p>Nick Soonthornchai<br \/>\n<br \/>1-973-443-2792 (o)<br \/>\n<br \/><a target=\"_blank\" href=\"m&#97;&#105;&#x6c;&#x74;&#x6f;&#x3a;n&#105;&#99;&#107;&#x2e;&#x73;&#x6f;on&#116;&#104;&#x6f;&#x72;&#x6e;ch&#97;&#105;&#x40;&#x7a;&#x6f;et&#105;&#115;&#x2e;&#x63;&#x6f;m\" rel=\"nofollow noopener\" shape=\"rect\">&#x6e;&#105;c&#x6b;&#x2e;&#115;o&#x6f;&#110;t&#x68;&#x6f;&#114;n&#x63;&#104;a&#x69;&#x40;&#122;o&#x65;&#x74;&#105;&#x73;&#x2e;&#99;o&#x6d;<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>PARSIPPANY, N.J.&#8211;(BUSINESS WIRE)&#8211;$ZTS #Fortune500&#8212;Zoetis Inc. (NYSE:ZTS) will participate in the Morgan Stanley 20th Annual Global Healthcare Conference on Tuesday, September 13, 2022. Wetteny Joseph, Executive Vice President and Chief Financial Officer, will represent the company and respond to questions from analysts. He is scheduled to present at 2:05 p.m. ET. Investors and other interested parties &#8230; <span class=\"more\"><a class=\"more-link\" href=\"https:\/\/pharma-trend.com\/en\/zoetis-to-participate-in-the-morgan-stanley-20th-annual-global-healthcare-conference\/\">[Read more&#8230;]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-48165","6":"format-standard","7":"category-industry"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Zoetis to Participate in the Morgan Stanley 20th Annual Global Healthcare Conference - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/zoetis-to-participate-in-the-morgan-stanley-20th-annual-global-healthcare-conference\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Zoetis to Participate in the Morgan Stanley 20th Annual Global Healthcare Conference - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"PARSIPPANY, N.J.&#8211;(BUSINESS WIRE)&#8211;$ZTS #Fortune500&#8212;Zoetis Inc. (NYSE:ZTS) will participate in the Morgan Stanley 20th Annual Global Healthcare Conference on Tuesday, September 13, 2022. Wetteny Joseph, Executive Vice President and Chief Financial Officer, will represent the company and respond to questions from analysts. He is scheduled to present at 2:05 p.m. ET. Investors and other interested parties ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/zoetis-to-participate-in-the-morgan-stanley-20th-annual-global-healthcare-conference\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-09-09T13:01:48+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20220908005770\/en\/356607\/21\/Zoetis_c.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/zoetis-to-participate-in-the-morgan-stanley-20th-annual-global-healthcare-conference\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/zoetis-to-participate-in-the-morgan-stanley-20th-annual-global-healthcare-conference\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Zoetis to Participate in the Morgan Stanley 20th Annual Global Healthcare Conference\",\"datePublished\":\"2022-09-09T13:01:48+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/zoetis-to-participate-in-the-morgan-stanley-20th-annual-global-healthcare-conference\\\/\"},\"wordCount\":255,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/zoetis-to-participate-in-the-morgan-stanley-20th-annual-global-healthcare-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220908005770\\\/en\\\/356607\\\/21\\\/Zoetis_c.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/zoetis-to-participate-in-the-morgan-stanley-20th-annual-global-healthcare-conference\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/zoetis-to-participate-in-the-morgan-stanley-20th-annual-global-healthcare-conference\\\/\",\"name\":\"Zoetis to Participate in the Morgan Stanley 20th Annual Global Healthcare Conference - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/zoetis-to-participate-in-the-morgan-stanley-20th-annual-global-healthcare-conference\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/zoetis-to-participate-in-the-morgan-stanley-20th-annual-global-healthcare-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220908005770\\\/en\\\/356607\\\/21\\\/Zoetis_c.jpg\",\"datePublished\":\"2022-09-09T13:01:48+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/zoetis-to-participate-in-the-morgan-stanley-20th-annual-global-healthcare-conference\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/zoetis-to-participate-in-the-morgan-stanley-20th-annual-global-healthcare-conference\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/zoetis-to-participate-in-the-morgan-stanley-20th-annual-global-healthcare-conference\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220908005770\\\/en\\\/356607\\\/21\\\/Zoetis_c.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220908005770\\\/en\\\/356607\\\/21\\\/Zoetis_c.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/zoetis-to-participate-in-the-morgan-stanley-20th-annual-global-healthcare-conference\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Zoetis to Participate in the Morgan Stanley 20th Annual Global Healthcare Conference\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Zoetis to Participate in the Morgan Stanley 20th Annual Global Healthcare Conference - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/zoetis-to-participate-in-the-morgan-stanley-20th-annual-global-healthcare-conference\/","og_locale":"en_US","og_type":"article","og_title":"Zoetis to Participate in the Morgan Stanley 20th Annual Global Healthcare Conference - Pharma Trend","og_description":"PARSIPPANY, N.J.&#8211;(BUSINESS WIRE)&#8211;$ZTS #Fortune500&#8212;Zoetis Inc. (NYSE:ZTS) will participate in the Morgan Stanley 20th Annual Global Healthcare Conference on Tuesday, September 13, 2022. Wetteny Joseph, Executive Vice President and Chief Financial Officer, will represent the company and respond to questions from analysts. He is scheduled to present at 2:05 p.m. ET. Investors and other interested parties ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/zoetis-to-participate-in-the-morgan-stanley-20th-annual-global-healthcare-conference\/","og_site_name":"Pharma Trend","article_published_time":"2022-09-09T13:01:48+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20220908005770\/en\/356607\/21\/Zoetis_c.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/zoetis-to-participate-in-the-morgan-stanley-20th-annual-global-healthcare-conference\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/zoetis-to-participate-in-the-morgan-stanley-20th-annual-global-healthcare-conference\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Zoetis to Participate in the Morgan Stanley 20th Annual Global Healthcare Conference","datePublished":"2022-09-09T13:01:48+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/zoetis-to-participate-in-the-morgan-stanley-20th-annual-global-healthcare-conference\/"},"wordCount":255,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/zoetis-to-participate-in-the-morgan-stanley-20th-annual-global-healthcare-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220908005770\/en\/356607\/21\/Zoetis_c.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/zoetis-to-participate-in-the-morgan-stanley-20th-annual-global-healthcare-conference\/","url":"https:\/\/pharma-trend.com\/en\/zoetis-to-participate-in-the-morgan-stanley-20th-annual-global-healthcare-conference\/","name":"Zoetis to Participate in the Morgan Stanley 20th Annual Global Healthcare Conference - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/zoetis-to-participate-in-the-morgan-stanley-20th-annual-global-healthcare-conference\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/zoetis-to-participate-in-the-morgan-stanley-20th-annual-global-healthcare-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220908005770\/en\/356607\/21\/Zoetis_c.jpg","datePublished":"2022-09-09T13:01:48+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/zoetis-to-participate-in-the-morgan-stanley-20th-annual-global-healthcare-conference\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/zoetis-to-participate-in-the-morgan-stanley-20th-annual-global-healthcare-conference\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/zoetis-to-participate-in-the-morgan-stanley-20th-annual-global-healthcare-conference\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20220908005770\/en\/356607\/21\/Zoetis_c.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20220908005770\/en\/356607\/21\/Zoetis_c.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/zoetis-to-participate-in-the-morgan-stanley-20th-annual-global-healthcare-conference\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Zoetis to Participate in the Morgan Stanley 20th Annual Global Healthcare Conference"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/48165","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=48165"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/48165\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=48165"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=48165"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=48165"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}